MAPT and Alzheimer disease: In a previous study, Espuny-Camacho et al.24 implanted human iPSC neurons into AD mouse models, after 6 months this chimeric mouse model recapitulates pTau induction and human neuronal sensitivity phenotypes and thus generated early tau pathological features but no robust tau aggregates.